Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/AJP.0000000000001323 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multimodal Psychobehavioral Interventions for Lung Cancer-Related Pain: A Protocol Development and Validation Study Examining the Mediating Role of Self-Efficacy in the Relationship Between Pain Perception and Adaptive Coping Strategies.
Cancer Manag Res
September 2025
Department of Pain, The First People's Hospital of Zunyi City, Zunyi, Guizhou, 563000, People's Republic of China.
Objective: To evaluate the effects of a comprehensive intervention program on cancer pain and self-efficacy in patients with lung cancer.
Methods: A total of 120 lung cancer patients with cancer pain who received treatment from January 2021 to December 2023 at The First People's Hospital of Zunyi were enrolled in this study. A within-subject design was used, comparing patients' pain and self-efficacy scores before and after a comprehensive intervention.
Comparison of the Efficacy of Low-Energy Delicate Pulsed Light and Q-Switched 1064 nm Nd:YAG Laser in the Treatment of Post-Acne Erythema: A Prospective Randomized Split-Face Study.
Lasers Surg Med
September 2025
Department of Dermatology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Objectives: Post-acne erythema (PAE), a common consequence of acne, is characterized by capillary dilation and erythema, which significantly impact facial aesthetics and quality of life. This study aims to evaluate and compare the efficacy and safety of intense pulsed light (DPL) and 1064 nm Q-switched Nd:YAG laser in treating PAE.
Methods: This prospective, randomized, self-controlled, evaluator-blinded clinical trial compared DPL and 1064 nm Q-switched Nd:YAG laser treatments on one side of the face, with biweekly sessions for 6 weeks.
Mechanisms of change in cognitive functional therapy: A longitudinal mediation analysis of the RESTORE clinical trial for disabling chronic low back pain.
Behav Res Ther
September 2025
Curtin School of Allied Health, Curtin University, Perth, Australia.
Chronic low back pain (CLBP) is an urgent global health priority given its high prevalence and impact as the leading cause of disability. While several efficacious treatments exist, most have modest effects. Improving outcomes requires a better understanding of treatment mechanisms to enable optimisation.
View Article and Find Full Text PDFFeasibility of a Gamified Mobile-Based Self-Management Intervention for Individuals With Nonspecific Chronic Lower Back Pain.
Nurs Res
September 2025
College of Nursing & Institute of Nursing Research, Korea University, Seoul, South Korea.
Background: Existing research fails to address the complex nature of nonspecific chronic lower back pain (cLBP ) despite its detrimental effect on economic, societal, and medical expenditures.
Objectives: We developed a nurse-led, mobile-delivered self-management intervention-Problem-Solving Pain to Enhance Living Well (PROPEL-M)-and evaluated its usability, feasibility, and initial efficacy for South Korean adults with nonspecific cLBP.
Methods: This study was composed of two phases: (a) lab and field usability testing for a gamified mobile device application; and (b) a pilot study employing a one-arm pre-test and post-test design among adults aged 18-60 years with nonspecific cLBP.
Ticagrelor Versus Clopidogrel in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Catheter Cardiovasc Interv
September 2025
Escuela de Medicina, Universidad Peruana Unión, Lima, Peru.
Background: Current guidelines recommend clopidogrel in patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI), yet the comparative benefits are unclear.
Aims: The aim of this study was to evaluate the efficacy and safety of ticagrelor versus clopidogrel in patients with CCS undergoing PCI.
Methods: We searched PubMed/MEDLINE, EMBASE, CENTRAL databases from inception to February 15, 2025.